Brian Erstad, PharmD, has been appointed to a three-year term on the Board of Pharmacy Specialties board of directors. Erstad hopes to advance the mission of BPS after years of leadership roles with UArizona. Read more: https://t.co/802aoAe68b
DANCE Trial Published 🔥🔥
NEW @CMIJournal
Antibiotic treatment for 6 days versus 12 days in patients with severe cellulitis: a multicentre randomised, double-blind, placebo-controlled, non-inferiority trial. #IDTwitter https://t.co/WiTJbKs5pn
🚨 Please Retweet! Early enteral #nutrition (EN) w/in 3 d of ICU admit improves outcomes in #COVID19 w/
⬇️ ICU & Hosp LOS
⬇️ Vent Days
⬇️ Costs
😱 40% of COVID19 ICU pts get no EN til post-ICU day 3 (avg 1st EN @ 10 d)
@CritCareExplore#SCCM2022#FOAMcc
https://t.co/jQ3cTympvE
Heartbreaking news today. Lost a friend/trauma patient. 3 years after a construction accident and 2 intestinal transplants, he went down fighting and with a smile. The human spirit is some of the best medicine. I’m a better pharmacist because of him.
We are EXCITED to announce that we will be publishing updated systematic reviews on 53 nutrition topics in critical care at https://t.co/murWS4fr1J . The first 6 topics are updated starting with the use of EN vs PN! Check it out! @DarenHeyland#ICU#criticalcare#ICUNutrition#RD
About 27% of Americans say they definitely or probably won’t get a #Covid19vaccine, even if it’s free and deemed safe by scientists. The behavioral obstacles to widespread vaccination are thus as important to understand as the scientific and logistic hurdles. #IDTwitter
NEW: IDSA Guidelines on the Treatment & Management of Patients with COVID-19 Infection. These evidence-based rapid guidelines, updated in real-time, will address pressing clinical questions related to caring for patients w/ COVID-19: https://t.co/mvi9Paa8Xv #COVID19Guidelines